Sunitinib Mylan 37.5mg hard capsules Malta - engelsk - Medicines Authority

sunitinib mylan 37.5mg hard capsules

mylan ireland limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - sunitinib - hard capsule - sunitinib 37.5 mg - antineoplastic agents

Sunitinib Mylan 50mg hard capsules Malta - engelsk - Medicines Authority

sunitinib mylan 50mg hard capsules

mylan ireland limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - sunitinib - hard capsule - sunitinib 50 mg - antineoplastic agents

Sunitinib Remedica 12.5mg Hard Capsules Malta - engelsk - Medicines Authority

sunitinib remedica 12.5mg hard capsules

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - sunitinib - hard capsule - sunitinib 12.5 mg - antineoplastic agents

Sunitinib Remedica 25mg Hard Capsules Malta - engelsk - Medicines Authority

sunitinib remedica 25mg hard capsules

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - sunitinib - hard capsule - sunitinib 25 mg - antineoplastic agents

Sunitinib Remedica 37.5mg Hard Capsules Malta - engelsk - Medicines Authority

sunitinib remedica 37.5mg hard capsules

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - sunitinib - hard capsule - sunitinib 37.5 mg - antineoplastic agents

Sunitinib Remedica 50mg Hard Capsules Malta - engelsk - Medicines Authority

sunitinib remedica 50mg hard capsules

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - sunitinib - hard capsule - sunitinib 50 mg - antineoplastic agents

Sunitinib Krka 12.5 mg hard capsules Irland - engelsk - HPRA (Health Products Regulatory Authority)

sunitinib krka 12.5 mg hard capsules

krka, d.d., novo mesto - sunitinib - capsule, hard - 12.5 milligram(s) - sunitinib

Sunitinib Krka 25 mg hard capsules Irland - engelsk - HPRA (Health Products Regulatory Authority)

sunitinib krka 25 mg hard capsules

krka, d.d., novo mesto - sunitinib - capsule, hard - 25 milligram(s) - sunitinib

Sunitinib Krka 50 mg hard capsules Irland - engelsk - HPRA (Health Products Regulatory Authority)

sunitinib krka 50 mg hard capsules

krka, d.d., novo mesto - sunitinib - capsule, hard - 50 milligram(s) - sunitinib

SUNITINIB MALATE capsule USA - engelsk - NLM (National Library of Medicine)

sunitinib malate capsule

sun pharmaceutical industries inc. - sunitinib malate (unii: lvx8n1ut73) (sunitinib - unii:v99t50803m) - sunitinib malate capsules are indicated for the treatment of adult patients with gastrointestinal stromal tumor (gist) after disease progression on or intolerance to imatinib mesylate. sunitinib malate capsules are indicated for the treatment of adult patients with advanced renal cell carcinoma (rcc). sunitinib malate capsules are indicated for the adjuvant treatment of adult patients at high risk of recurrent rcc following nephrectomy. sunitinib malate capsules are indicated for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumors (pnet) in adult patients with unresectable locally advanced or metastatic disease. none. risk summary based on animal reproduction studies and its mechanism of action, sunitinib can cause fetal harm when administered to a pregnant woman [see clinical pharmacology (12.1)] . there are no available data in pregnant women to inform a drug-associated risk. in animal developmental and reproductive toxicology studies, oral administration of sunitinib to pregn